MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹85 Cr | ₹83 Cr | ₹73 Cr | ₹53 Cr | ₹56 Cr |
What is the latest Total Current Liabilities ratio of MEDICAMEN BIOTECH ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹85 Cr |
Mar2023 | ₹83 Cr |
Mar2022 | ₹73 Cr |
Mar2021 | ₹53 Cr |
Mar2020 | ₹56 Cr |
How is Total Current Liabilities of MEDICAMEN BIOTECH Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹85 Cr | 2.40 | |
Mar2023 | ₹83 Cr | 13.60 | |
Mar2022 | ₹73 Cr | 36.45 | |
Mar2021 | ₹53 Cr | -5.68 | |
Mar2020 | ₹56 Cr | - |
Compare Total Current Liabilities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹584.6 Cr | 2.9% | -12.1% | -14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,228.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,023.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹119,474.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,599.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,604.7 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | 2.9% |
-12.1% |
-14.5% |
SENSEX | 1.7% |
-1.3% |
7.7% |
You may also like the below Video Courses